Diabetes, Mitral Repair And Diagnostics Drive Big Quarter For Abbott
The company’s worldwide medical devices business reported 10.6% organic growth for the third quarter of 2019.
Abbott Laboratories’ medical device businesses grew 10.6% year over year in the third quarter of 2019 while its diagnostics business grew 6.6%, helping the company grow 7.6% overall, the company reported on 16 October.
